
Ossium Health’s Kevin Caldwell joins The Ron Lanton Report to explain how banked, deceased-donor marrow is replacing a months-long search for a living donor with a product hospitals can order on demand.
Some good news, some bad news for biotechnology patent holders
over 24 years ago
Facilitating Client Audits: The Contract Laboratory Perspectiveover 24 years ago
Knowledge Management: The Four Pillars of Successover 24 years ago
Inside Washington: One Hundred Years of Biotech Regulation





